Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A second functional furin site in the SARS-CoV-2 spike protein
Yue Zhang, Li Zhang, Jiajing Wu, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 182-194
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults
Kun Xu, Zihan Wang, Maorong Qin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Host range, transmissibility and antigenicity of a pangolin coronavirus
Yixuan J. Hou, S. Chiba, Sarah R. Leist, et al.
Nature Microbiology (2023) Vol. 8, Iss. 10, pp. 1820-1833
Open Access | Times Cited: 22
SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
Nina Reuter, Xiaohan Chen, Barbara Kropff, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1500-1500
Open Access | Times Cited: 20
Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
Harry Ridgway, Charalampos Ntallis, Christos T. Chasapis, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 309-309
Open Access | Times Cited: 17
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals
Jimena Pérez‐Vargas, Gabriel Lemieux, Connor A.H. Thompson, et al.
Antiviral Research (2024) Vol. 225, pp. 105869-105869
Open Access | Times Cited: 6
Digital modeling by biomedical informatics analysis predicts suppression of COVID-19 infectivity via ‘targeting oligonucleotide-directed devolution’
Frank Hong, M. Castro, Klaus D. Linse
(2025) Vol. 3
Closed Access
Repositioning of Furin inhibitors as potential drugs against SARS-CoV-2 through computational approaches
Asmae Saih, Soukayna Baammi, Hicham Charoute, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-15
Closed Access
W254 in furin functions as a molecular gate promoting anti-viral drug binding: Elucidation of putative drug tunneling and docking by non-equilibrium molecular dynamics
Harry Ridgway, John D. Orbell, Minos‐Timotheos Matsoukas, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 4589-4612
Open Access | Times Cited: 8
Host Cell Proteases Mediating SARS-CoV-2 Entry: An Overview
Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 21, pp. 1776-1792
Open Access | Times Cited: 14
Capturing a Crucial ‘Disorder-to-Order Transition’ at the Heart of the Coronavirus Molecular Pathology—Triggered by Highly Persistent, Interchangeable Salt-Bridges
Sourav Roy, Prithwi Ghosh, Abhirup Bandyopadhyay, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 301-301
Open Access | Times Cited: 12
SARS-CoV-2-related bat viruses evade human intrinsic immunity but lack efficient transmission capacity
Mario A. Peña-Hernández, Mia Madel Alfajaro, Renata B. Filler, et al.
Nature Microbiology (2024) Vol. 9, Iss. 8, pp. 2038-2050
Closed Access | Times Cited: 2
Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots
Paul F. Gillespie, Yanjie Wang, Carl Hofmann, et al.
ACS Omega (2023) Vol. 8, Iss. 3, pp. 3319-3328
Open Access | Times Cited: 6
Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus
Davide Bassani, Eugenio Ragazzi, Annunziata Lapolla, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 9
Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation
Shiu‐Wan Chan
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2
Yong Ma, Pengbin Li, Yunqi Hu, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011123-e1011123
Open Access | Times Cited: 5
Optimization and validation of a virus‐like particle pseudotyped virus neutralization assay for SARS‐CoV‐2
Shuo Liu, Li Zhang, Wangjun Fu, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 1
Visually distinguishing between tumor tissue and healthy tissue within ten minutes using proteolytic probes
Debora Reinhardt, Björn ter Mors, Marc D. Drießen, et al.
Sensors & Diagnostics (2024) Vol. 3, Iss. 8, pp. 1319-1328
Open Access | Times Cited: 1
Docking, MD Simulations, and DFT Calculations: Assessing W254’s Function and Sartan Binding in Furin
Nikitas Georgiou, Thomas Mavromoustakos, Demeter Tzeli
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8226-8238
Open Access | Times Cited: 1
Diphyllin elicits a doubled-pronged attack on the entry of SARS-CoV-2 by inhibiting cathepsin L and furin
Binli Mao, Vu Thuy Khanh Le‐Trilling, Haoran Tang, et al.
Virus Research (2024) Vol. 350, pp. 199485-199485
Open Access | Times Cited: 1
Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants
Rashed Noor
Viruses (2022) Vol. 14, Iss. 11, pp. 2541-2541
Open Access | Times Cited: 7
A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model
Jian Ma, Xuan Liu, Ming Zhou, et al.
Journal of Virology (2023) Vol. 97, Iss. 2
Open Access | Times Cited: 3
Cooperative and structural relationships of the trimeric Spike with infectivity and antibody escape of the strains Delta (B.1.617.2) and Omicron (BA.2, BA.5, and BQ.1)
Anacleto Silva de Souza, Robson Francisco de Souza, Cristiane Rodrigues Guzzo
Journal of Computer-Aided Molecular Design (2023) Vol. 37, Iss. 12, pp. 585-606
Open Access | Times Cited: 2
COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation
Yuanling Yu, Mengyi Zhang, Lan Huang, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 763-763
Open Access
New Strategies for Responding to SARS-CoV-2: The Present and Future of Dual-Target Drugs
Wenyi Zhang, Lecheng Xiao, D. Li, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses
Harry Ridgway, Vasso Apostolopoulos, Graham J. Moore, et al.
Viruses (2024) Vol. 16, Iss. 11, pp. 1776-1776
Open Access
Page 1 - Next Page

Scroll to top